Investor Presentaiton

Investor presentation ADA 2019 Slide 2 Agenda CV aspects of GLP-1s and clinical developments with OzempicⓇ PIONEER highlights Driving innovation in insulin Obesity and NASH pipeline The increasing focus on Real-World Evidence Regulatory update changing diabetes novo nordisk

View entire presentation